{
    "title": "RSS Feed Title",
    "link": "https://example.com",
    "description": "RSS Feed Description",
    "lastBuildDate": "2024-09-30T12:28:47.557524",
    "items": [
        {
            "title": "Cantabil Retail India: Demand to pick up from H2; valuations attractive",
            "link": "https://www.moneycontrol.com/news/business/stocks/cantabil-retail-india-demand-to-pick-up-from-h2-valuations-attractive-12832106.html",
            "description": "With roughly 550 stores now, CRIL has huge potential to expand. Moreover, CRIL is not present in South India now and aims to enter that market after two years, which indicates huge growth potential.",
            "pubDate": "2024-09-30T04:55:31.486121"
        },
        {
            "title": "Tata iPhone component plant halts production indefinitely after fire",
            "link": "https://www.moneycontrol.com/news/business/companies/tata-iphone-component-plant-halts-production-indefinitely-after-fire-12832535.html",
            "description": "Tata Electronics, part of the $165 billion Indian salt-to-software Tata Group, is one of the major suppliers for Apple in India, along with Taiwan's Foxconn",
            "pubDate": "2024-09-30T10:21:32.417046"
        },
        {
            "title": "Tata Power signs MoU with Rajasthan govt to invest Rs 1.2 lakh cr in power sector",
            "link": "https://www.moneycontrol.com/news/business/companies/tata-power-signs-mou-with-rajasthan-govt-to-invest-rs-1-2-lakh-cr-in-power-sector-12832632.html",
            "description": "The ambitious 10-year plan aims to support Rajasthan's transformation into a power surplus state, providing 24/7 clean, affordable, and reliable power supply with investments in renewable energy projects and manufacturing, transmission, distribution, nuclear power, rooftop installations, and EV charging",
            "pubDate": "2024-09-30T11:25:05.313106"
        },
        {
            "title": "Mankind Pharma board approves up to Rs 10,000 crore fundraising plan",
            "link": "https://www.moneycontrol.com/news/business/companies/mankind-pharma-board-approves-up-to-rs-10000-crore-fundraising-plan-12832688.html",
            "description": "The company, however, did not disclose how it aims to utilise the raised capital. In July this year, Mankind had announced the acquisition of Bharat Serums and Vaccines from Advent International for around Rs 13,630 crore",
            "pubDate": "2024-09-30T12:28:46.876473"
        }
    ]
}